Global Cancer Registry Software Market 2024-2028
The cancer registry software market is forecasted to grow by USD 97.1 mn during 2023-2028, accelerating at a CAGR of 12.75% during the forecast period. The report on the cancer registry software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of cancer cases, growing number of cancer registries, and increasing partnerships to improve cancer registries.
Technavio's cancer registry software market is segmented as below:
By End-user
- Government and third party
- Pharma biotech and medical device companies
- Hospitals and medical practice
- Private payers
- Research institutes
By Type
- Stand-alone software
- Integrated software
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing clinical research for oncology as one of the prime reasons driving the cancer registry software market growth during the next few years. Also, rising integration of AI and machine learning and increasing adoption of EHRS for cancer registries will lead to sizable demand in the market.
The report on the cancer registry software market covers the following areas:
- Cancer registry software market sizing
- Cancer registry software market forecast
- Cancer registry software market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cancer registry software market vendors that include CDC, Conduent Inc., Elekta AB, ERS Inc., Inspirata Inc., International Association of Cancer Registries, International Business Machines Corp., McKesson Corp., NeuralFrame Inc., OMH HealthEdge Holdings LLC, Onco Inc., Ordinal Data Inc., Redsson Ltd., Siemens AG, and University of Utah Health. Also, the cancer registry software market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.